AbCellera Biologics, Inc. ABCL
NASDAQ · United States · Health Technology
$14.59-0.23 (-1.55%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.18 | -0.16 | -9.8% | $4.05M | -48.4% | +7.2%$6.09→$6.53 |
| Q1 2026 | 2026-05-11 | -0.14 | -0.20 | +30.0% | — | — | -5.5%$5.24→$4.95 |
| Q4 2025 | 2026-02-24 | -0.03 | -0.18 | +83.3% | — | — | +5.3%$3.03→$3.19 |
| Q3 2025 | 2025-11-06 | -0.19 | -0.16 | -18.8% | — | — | -16.6%$4.69→$3.91 |
| Q2 2025 | 2025-08-07 | -0.12 | -0.16 | +25.0% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.15 | -0.14 | -7.1% | — | — | — |
| Q4 2024 | 2025-02-27 | -0.12 | -0.15 | +20.0% | — | — | — |
| Q3 2024 | 2024-11-04 | -0.17 | -0.13 | -30.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.